| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 211.876 | 140.710 | 140.019 | 144.025 | 129.800 | 123.328 | 115.652 | 149.202 | 170.537 | 162.993 |
| Total Income - EUR | 211.876 | 140.712 | 140.020 | 144.026 | 129.802 | 123.329 | 115.652 | 149.205 | 170.541 | 162.997 |
| Total Expenses - EUR | 187.441 | 148.009 | 136.951 | 139.274 | 124.136 | 122.309 | 119.252 | 145.456 | 167.111 | 162.359 |
| Gross Profit/Loss - EUR | 24.435 | -7.296 | 3.069 | 4.752 | 5.666 | 1.020 | -3.599 | 3.749 | 3.429 | 638 |
| Net Profit/Loss - EUR | 21.341 | -7.296 | 965 | 3.186 | 4.368 | 191 | -4.453 | 2.585 | 2.226 | 555 |
| Employees | 4 | 2 | 2 | 1 | 1 | 2 | 2 | 1 | 1 | 1 |
Check the financial reports for the company - Antibakterialis Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 13.885 | 13.017 | 10.431 | 8.104 | 5.985 | 4.182 | 18.420 | 15.319 | 12.917 | 10.531 |
| Current Assets | 28.576 | 15.300 | 10.125 | 12.167 | 47.173 | 15.352 | 21.103 | 28.103 | 25.075 | 18.018 |
| Inventories | 2.771 | 9.607 | 2.694 | 6.837 | 9.354 | 12.664 | 14.820 | 14.920 | 12.108 | 13.773 |
| Receivables | 3.205 | 5.429 | 3.669 | 2.560 | 2.473 | 823 | 2.366 | 6.997 | 5.417 | 1.267 |
| Cash | 22.600 | 264 | 3.761 | 2.770 | 35.346 | 1.865 | 3.916 | 6.186 | 7.550 | 2.978 |
| Shareholders Funds | 22.188 | 5.535 | 6.407 | 9.476 | 13.660 | 13.964 | 9.202 | 11.815 | 14.005 | 14.482 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 413 | 404 | 406 | 404 | 402 |
| Debts | 20.274 | 22.782 | 14.148 | 10.796 | 39.498 | 5.600 | 30.321 | 33.432 | 23.987 | 14.535 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4520 - 4520" | |||||||||
| CAEN Financial Year |
4520
|
|||||||||
Comments - Antibakterialis Srl